Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype
- 26 August 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 13 (9), 1086-1095
- https://doi.org/10.1038/nm1626
Abstract
Dyslipidemia is associated with a prothrombotic phenotype; however, the mechanisms responsible for enhanced platelet reactivity remain unclear. Proatherosclerotic lipid abnormalities are associated with both enhanced oxidant stress and the generation of biologically active oxidized lipids, including potential ligands for the scavenger receptor CD36, a major platelet glycoprotein. Using multiple mouse in vivo thrombosis models, we now demonstrate that genetic deletion of Cd36 protects mice from hyperlipidemia-associated enhanced platelet reactivity and the accompanying prothrombotic phenotype. Structurally defined oxidized choline glycerophospholipids that serve as high-affinity ligands for CD36 were at markedly increased levels in the plasma of hyperlipidemic mice and in the plasma of humans with low HDL levels, were able to bind platelets via CD36 and, at pathophysiological levels, promoted platelet activation via CD36. Thus, interactions of platelet CD36 with specific endogenous oxidized lipids play a crucial role in the well-known clinical associations between dyslipidemia, oxidant stress and a prothrombotic phenotype.This publication has 49 references indexed in Scilit:
- Light-induced Oxidation of Photoreceptor Outer Segment Phospholipids Generates Ligands for CD36-mediated Phagocytosis by Retinal Pigment EpitheliumOnline Journal of Public Health Informatics, 2006
- Aspirin and clopidogrel resistance: an emerging clinical entityEuropean Heart Journal, 2005
- A Role for Oxidized Phospholipids in AtherosclerosisThe New England Journal of Medicine, 2005
- CD36 is a sensor of diacylglyceridesNature, 2005
- Stem Cell Transplantation Reveals That Absence of Macrophage CD36 Is Protective Against AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Enhanced Thrombosis in Atherosclerosis-Prone Mice Is Associated With Increased Arterial Expression of Plasminogen Activator Inhibitor-1Arteriosclerosis, Thrombosis, and Vascular Biology, 2003
- CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolismJCI Insight, 2001
- Recombinant Glutathione S-Transferase/CD36 Fusion Proteins Define an Oxidized Low Density Lipoprotein-binding DomainOnline Journal of Public Health Informatics, 1998
- Platelet Hyperreactivity and Prognosis in Survivors of Myocardial InfarctionThe New England Journal of Medicine, 1990
- Effect of Cholesterol on Production of Thromboxane B2by Platelets in VitroThe New England Journal of Medicine, 1980